Antoni Castro
- Hematology top 2%
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 19
- Internal Medicine top 5%
- Microbiology top 10%
- Genetics top 5%
-
- Atherosclerosis and Cardiovascular Diseases 10
-
- Adipokines, Inflammation, and Metabolic Diseases 10
-
- COVID-19 Clinical Research Studies 9
-
- Paraoxonase enzyme and polymorphisms 8
-
- Innovations in Medical Education 8
-
- Pancreatitis Pathology and Treatment 7
-
- Lipid metabolism and disorders 7
- Co-authors
- José Manuel Fernández‐RealWifredo RicartGeorgina PeñarrojaF García‐BragadoIldefonso Hernández‐AguadoRoser CasamitjanaAbel López‐BermejoFrancisco Ortega
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Antoni Castro
96 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 355
- Rheumatology 425
- Internal Medicine 92
- Microbiology 14
- Genetics 177
Countries citing papers authored by Antoni Castro
This map shows the geographic impact of Antoni Castro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoni Castro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoni Castro more than expected).
Fields of papers citing papers by Antoni Castro
This network shows the impact of papers produced by Antoni Castro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoni Castro. The network helps show where Antoni Castro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antoni Castro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 0 | |
| 10 | 2021 | 14 | |
| 11 | 2019 | 13 | |
| 12 | 2017 | 56 | |
| 13 | 2017 | 0 | |
| 14 | 2016 | 23 | |
| 15 | 2016 | 13 | |
| 16 | 2016 | 15 | |
| 17 | 2015 | 11 | |
| 18 | Nou grau de Medicina a la Universitat Rovira i Virgili a partir d’un procés de reflexió entorn a l’Espai Europeu d’Educació Superior | 2008 | 0 |
| 19 | 2005 | 20 | |
| 20 | Uveitis posterior bilateral como forma de presentación de sarcoidosis. | 2003 | 0 |
About Antoni Castro
Antoni Castro is a scholar working on Family Practice, Rheumatology, Microbiology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine, having authored 108 papers that have together received 2.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (19 papers), Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), COVID-19 Clinical Research Studies (9 papers), Paraoxonase enzyme and polymorphisms (8 papers), Innovations in Medical Education (8 papers), Pancreatitis Pathology and Treatment (7 papers) and Lipid metabolism and disorders (7 papers). The work is most often cited by research in Hematology (355 citations), Rheumatology (425 citations), Internal Medicine (92 citations), Microbiology (14 citations) and Genetics (177 citations). Antoni Castro has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include José Manuel Fernández‐Real, Wifredo Ricart, Georgina Peñarroja, F García‐Bragado, Ildefonso Hernández‐Aguado, Roser Casamitjana, Abel López‐Bermejo, Francisco Ortega, Abel López‐Bermejo and José María Moreno‐Navarrete. Their work appears in journals such as Biomolecules, Diabetes Care, Annals of the Rheumatic Diseases, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.